Back to search

National and Kapodistrian University of Athens

Ο ρόλος του CRH στην in vitro ανάπτυξη αρχέγονων ωοθυλακίων και η δράση αυτού στην εμφύτευση

Abstract

dc:description

Ζ. SUMMARYIntroductionThe hormone CRH (corticotropin releasing hormone) is a neuropeptide which is the main regulator of the hypothalamic-pituitary-adrenal (HPA axis). It is detectable in most female reproductive tissues, including the placenta, uterus and ovaries, and interacts with two receptors, the CRH-R1 and the CRH-R2. According to previous studies in women with repeated implantation failures, increasing rates of pregnancies after intrauterine infusion of peripheral blood monocytes (PBMCs) supplemented with hCG and/or CRH were found. The CRH is a key hormone during both desidualization of the endometrium and in maternal-fetal immunotolerance. Moreover, integrins are a family of transmembrane glycoproteins with αvβ3 to has been proposed as a potential fetal receptor binding and αvβ5 to be present in the endometrium at the time of implantation.The purpose of this study was to investigate the role of CRH in the in vitro development of preantral mouse follicles. For this reason, we examined the effect of hormone CRH and the inhibitor, antalarmin, in the in vitro maturation of preantral mouse follicles in early embryonic development but also in steroidogenesis, in producing glycoprotein hormones and a peptide hormone. We additionally performed Real-Time PCR to study the expression of genes encoding the CRH-R1 and CRH-R2 in preantral mouse follicles and stage mouse embryos 2-, 4- and 8-cells and mix of morulae-blastocysts. In this study we also chose to evaluate the effect of CRH in the implantation, in association with the expression of CRH, CRH-R1, CRH-R2 and integrins in women participating in the IVF program, and had more than two attempts of implantation failure.Materials and MethodsFemale mice F1 12-14 days were sacrificed and their ovaries were isolated and transferred to culture medium DPBS supplemented with 10% BSA (Bovine Serum Alboumin). Mechanically isolated follicles were cultured for 11 days in a-MEM supplemented with FSH, LH, ITS and FBS, with or without the addition of CRH at a concentration of 10-7 mol/L and CRH 10-7 mol/L and antalarmin 10-6 mol/ L. Every 48 hours the culture medium was renewed and was kept in the freezer for later measurement of estradiol, progesterone, testosterone, b-hCG, FSH, LH and prolactin by electrochemiluminescence immunoassay. After 10 days of culture we added 1.5 IU/ml hCG and 5 ng/ml EGF for ovulation. On day 11 we estimated the COCs (Cummulus-oocyte complexes) and transferred them after we sacrificed F1 male mice for in vitro fertilization. Embryos were cultured for 5 days in Ham's F10/BSA at a ratio of 9/1 in order to assess early fetal development. Finally, total RNA was isolated from the preantral follicles in culture days 3,5,7,9 and 11 as well as embryonic stages 2-, 4- and 8-cells and mix morulae-blastocysts in order to do Real-Time RT-PCR to study the expression of the CRH-R1 and CRH-R2 receptors.The clinical experimental protocol consisted of three stages to match three menstrual cycles of seven women who participated in this clinical study. The first menstrual cycle was natural cycle and was performed as the control cycle for each woman and two biopsies were taken, five and eight days after hCG. The second menstrual cycle was also natural but at this cycle we isolated the PBMCs, we treated them with CRH and hCG, we infused them intrauterine and finally endometrial biopsies were taken again. Then we isolated genetic material and by Real Time PCR we studied the expression of CRH, CRH-R1, CRH-R2 and integrins αvβ3 and αvβ5 before and after injection with CRH. In the third menstrual cycle the patients were taking the appropriate medications to stimulate ovulation. Simultaneously we isolated the PBMCs, we treated them with CRH and hCG, we infused them intrauterine with the difference that in this cycle we finally did embryo transfer to evaluate pregnancy rates.ResultsWe cultured 732 follicles in the control group, 1306 follicles in group CRH 10-7 and 1202 follicles in group CRH 10-7/antalarmin 10-6. The maturation rates for the control group were 33.6%, while for the group CRH 10-7 26,18%, showing a statistically significant reduction (p<0.001). Also there was a statistically significant difference between the control group and the group CRH 10-7 at all stages of development of preimplantation embryos and between the CRH 10-7 group and CRH 10-7/antalarmin 10-6 group. By hormonal assessment it was found that CRH group had significantly lower levels of estradiol, progesterone, testosterone and beta-hCG as days culture increased in comparison with the other two groups which gave statistically significant differences. The Real-Time RT-PCR showed that receptors CRH-R1,-R2 were detected at all stages of preantral follicles while regarding the preimplantation embryos, only at the mix morulae-blastocysts was detected the CRH-R1.The clinical protocol was compared the expression of CRH, CRH-R1, CRH-R2 and integrins αvβ3 and αvβ5 in the endometrium before and after infusion with CRH, 5 days after hCG and 8 days after hCG. There was a tendency of reduction of CRH expression which was not statistically significant, while the reduction of the receptors CRH-R1, R2 was statistically significant. For integrins there was a trend of increased expression without being statistically significant. Also there was no statistical significance in women's pregnancy rates (3/7 were pregnant, 42,9%, p> 0,05 MC Nemar test) when compared with the non-existence of pregnancy in previous cycles before injection with CRH.ConclusionsAccording to this study, CRH had a negative effect on follicular growth and maturation, as also it was found a statistically significant difference in the development of preimplantation embryos. The addition of specific CRH-R1 antagonist, antalarmin in in vitro cultures with CRH yielded higher survival rates in all embryonic stages, suggesting that antalarmin reverses the inhibitory effect of CRH. We have shown that the presence of CRH in a in vitro culture of preantral mouse follicles suppressed stereoeidogenesi while the CRH-R1 receptor was detected in all stages of culture of preantral follicles as in embryonic stages of morulae and blastocysts. Our results demonstrated the negative effect of CRH in the rates of early embryonic development in vitro fertilized oocytes. Since CRH is the principal hormone "stress", we could use this knowledge to optimize the quality of oocytes and early embryos during IVF techniques, controlling the levels of stress of the patients.Furthermore, according to this preliminary clinical pilot study there was a trend of increase of the expression of integrins αvβ3 and αvβ5 and a trend of decrease in CRH expression in the endometrium before and after infusion with CRH. But there was a statistically significant decrease in expression of the CRH-R1 receptors and CRH-R2. Further trials should be performed in order to increase the number of women and prove the effectiveness of treatment with CRH in women with repeated implantation failure.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntinopoulou, Vasiliki
  • Ντινοπούλου, Βασιλική

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35761

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntinopoulou, Vasiliki; Ντινοπούλου, Βασιλική. Ο ρόλος του CRH στην in vitro ανάπτυξη αρχέγονων ωοθυλακίων και η δράση αυτού στην εμφύτευση. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/35761